AVS MBA - Tykhe Corp COO Director
| HALB Stock | USD 0 0.0003 8.33% |
Insider
AVS MBA is COO Director of Tykhe Corp
| Age | 68 |
| Phone | 814 786 8849 |
| Web | https://halberdcorporation.com |
Tykhe Corp Management Efficiency
The company has return on total asset (ROA) of 0.0941 % which means that it generated a profit of $0.0941 on every $100 spent on assets. This is way below average. Tykhe Corp's management efficiency ratios could be used to measure how well Tykhe Corp manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Stephen JD | Geron | 74 | |
| Joseph Ferra | Elevation Oncology | 49 | |
| Piyush Gupta | Verastem | N/A | |
| David Dornan | Elevation Oncology | 46 | |
| Christian Mueller | Immutep Ltd ADR | N/A | |
| Brian Sullivan | Elevation Oncology | N/A | |
| Ryan Bloomer | Elevation Oncology | N/A | |
| Shengfei Fang | Immutep Ltd ADR | N/A | |
| Sean Flynn | Verastem | 50 | |
| Jonathan Pachter | Verastem | 66 | |
| BPHARM RPh | Verastem | 63 | |
| Valerie MD | Elevation Oncology | 46 | |
| Daniel Calkins | Verastem | 36 | |
| Erin Cox | Verastem | N/A | |
| Robert Weinberg | Verastem | N/A | |
| RPh PharmD | Elevation Oncology | 40 | |
| Wolfgang MD | Rigel Pharmaceuticals | 58 | |
| Mba MBA | Verastem | 70 | |
| Michelle MD | Verastem | 48 | |
Management Performance
| Return On Asset | 0.0941 |
Tykhe Corp Leadership Team
Elected by the shareholders, the Tykhe Corp's board of directors comprises two types of representatives: Tykhe Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Tykhe. The board's role is to monitor Tykhe Corp's management team and ensure that shareholders' interests are well served. Tykhe Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Tykhe Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Heidi Carl, Director Director | ||
| Mitchell MD, CTO Board | ||
| William Hartman, CEO Pres | ||
| MD FAAN, Chief Board | ||
| AVS MBA, COO Director |
Tykhe Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Tykhe Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | 0.0941 | |||
| Operating Margin | (245.49) % | |||
| Current Valuation | 1.56 M | |||
| Price To Earning | 3.67 X | |||
| Price To Book | 16.90 X | |||
| Price To Sales | 267.80 X | |||
| Revenue | 6.94 K | |||
| Gross Profit | 943 | |||
| EBITDA | 139.91 K | |||
| Net Income | (960.77 K) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Tykhe Pink Sheet
Tykhe Corp financial ratios help investors to determine whether Tykhe Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Tykhe with respect to the benefits of owning Tykhe Corp security.